| Literature DB >> 32195019 |
Kiichiro Baba1, Motoo Nomura1, Shinya Ohashi1, Takuya Hiratsuka2, Yukie Nakai1, Tomoki Saito1, Yuki Kondo1, Keita Fukuyama1, Osamu Kikuchi1, Atsushi Yamada1, Junichi Matsubara1, Kenshiro Hirohashi1, Yosuke Mitani1, Ayaka Mizumoto1, Manabu Muto1.
Abstract
Radiotherapy (RT) is the primary treatment for cancer. Ionizing radiation from RT induces tumor damage at the irradiated site, and, although clinically infrequent, may cause regression of tumors distant from the irradiated site-a phenomenon known as the abscopal effect. Recently, the abscopal effect has been related to prolongation of overall survival time in cancer patients, though the factors that influence the abscopal effect are not well understood. The aim of this study is to clarify the factors influencing on abscopal effect. Here, we established a mouse model in which we induced the abscopal effect. We injected MC38 (mouse colon adenocarcinoma) cells subcutaneously into C57BL/6 mice at two sites. Only one tumor was irradiated and the sizes of both tumors were measured over time. The non-irradiated-site tumor showed regression, demonstrating the abscopal effect. This effect was enhanced by an increase in the irradiated-tumor volume and by administration of anti-PD1 antibody. When the abscopal effect was induced by a combination of RT and anti-PD1 antibody, it was also influenced by radiation dose and irradiated-tumor volume. These phenomena were also verified in other cell line, B16F10 cells (mouse melanoma cells). These findings provide further evidence of the mechanism for, and factors that influence, the abscopal effect in RT. AJCREntities:
Keywords: Abscopal effect; anti-PD1 antibody; irradiated-tumor volume; radiation dose; radiotherapy; tumor-specific CD8+ T cells
Year: 2020 PMID: 32195019 PMCID: PMC7061743
Source DB: PubMed Journal: Am J Cancer Res ISSN: 2156-6976 Impact factor: 6.166